Osteoporosis in Men
What is Osteoporosis?
Osteoporosis is a disease characterized by low bone mass and deterioration of bone tissue, leading to increased bone fragility and risk of fractures. While often thought of as a "woman's disease," osteoporosis in men is more common than many realize and often underdiagnosed.
How Common is it in Men?
- 1 in 4 men over age 50 will have an osteoporotic fracture in their lifetime
- About 2 million American men have osteoporosis
- Men have HIGHER mortality rates after hip fractures than women (30-40% die within 1 year)
- Often diagnosed later than in women because men aren't routinely screened
Causes of Osteoporosis in Men:
Primary Osteoporosis:
- Age-related bone loss
- Idiopathic (no identifiable cause)
Secondary Osteoporosis (60% of cases in men):
- Hypogonadism (Most Common): Low testosterone—from aging, pituitary disorders, medications, or testicular damage
- Glucocorticoid Use: Prednisone, dexamethasone (most common medication cause)
- Alcohol Abuse: Excessive intake impairs bone formation
- Smoking
- Gastrointestinal Diseases: Celiac disease, IBD, malabsorption
- Chronic Kidney Disease
- Hyperthyroidism or Excess Thyroid Hormone
- Hyperparathyroidism
- Multiple Myeloma, Lymphoma
- Rheumatoid Arthritis, Chronic Liver Disease
- Medications: Anticonvulsants, proton pump inhibitors (long-term), chemotherapy
- Androgen Deprivation Therapy (ADT) for Prostate Cancer
Risk Factors:
- Age >70
- Low body weight (BMI <20)< /li>
- Previous fracture after age 50
- Family history of osteoporosis or hip fracture
- Sedentary lifestyle
- Low calcium and Vitamin D intake
- Excessive alcohol or caffeine
Diagnosis:
DEXA Scan (Dual-Energy X-ray Absorptiometry):
- Measures bone mineral density (BMD) at hip and spine
- T-score ≤ -2.5: Osteoporosis
- T-score -1.0 to -2.5: Osteopenia (low bone mass)
- T-score ≥ -1.0: Normal
Who should be screened?
- All men age 70 and older
- Men age 50-69 with risk factors (fracture, low testosterone, steroid use, etc.)
- Any man with a fragility fracture
Labs (to identify secondary causes):
- Testosterone (total and free), LH, FSH
- 25-OH Vitamin D
- Calcium, phosphorus, alkaline phosphatase
- TSH, parathyroid hormone (PTH)
- Complete blood count, liver function, kidney function
- Celiac screen (tissue transglutaminase antibody)
- Bone turnover markers (CTX, P1NP)—optional
Treatment:
1. Lifestyle Modifications:
- Weight-bearing exercise: Walking, jogging, resistance training
- Quit smoking
- Limit alcohol (≤2 drinks/day)
- Fall prevention: Home safety, balance exercises, vision check
2. Calcium and Vitamin D:
- Calcium: 1200 mg/day (diet + supplement)
- Vitamin D: 800-2000 IU/day; maintain 25-OH Vitamin D >30 ng/mL
3. Treat Underlying Causes:
- Testosterone replacement (if hypogonadal)
- Stop or minimize steroids (if possible)
- Treat hyperthyroidism, hyperparathyroidism
- Address alcohol abuse
4. Medications for Osteoporosis:
Bisphosphonates (First-Line):
- Alendronate (Fosamax®): 70 mg weekly (oral)
- Risedronate (Actonel®): 35 mg weekly (oral)
- Zoledronic Acid (Reclast®): 5 mg IV once yearly
- Reduce fracture risk by 40-70%
Denosumab (Prolia®):
- Subcutaneous injection every 6 months
- Very effective; alternative to bisphosphonates
Teriparatide (Forteo®) or Abaloparatide (Tymlos®):
- Daily subcutaneous injection (parathyroid hormone analogs)
- Anabolic agents—BUILD new bone
- Reserved for severe osteoporosis or multiple fractures
- Used for 1-2 years, then transition to anti-resorptive
Romosozumab (Evenity®):
- Monthly subcutaneous injection (sclerostin inhibitor)
- Both builds bone AND reduces breakdown
- Used for 12 months in very high-risk patients
When to Start Treatment:
- T-score ≤ -2.5 (osteoporosis)
- History of hip or vertebral fracture
- T-score -1.0 to -2.5 (osteopenia) + high FRAX score (10-year hip fracture risk ≥3% or major osteoporotic fracture risk ≥20%)
- Long-term glucocorticoid use (prednisone ≥5 mg/day for ≥3 months)
Monitoring:
- DEXA scan every 1-2 years while on treatment
- Reassess Vitamin D, calcium levels annually
- Monitor for side effects
Key Points:
- Osteoporosis in men is UNDERDIAGNOSED and UNDERTREATED
- Always look for secondary causes (especially low testosterone)
- Treatment reduces fracture risk significantly
- Men with hip fractures have worse outcomes than women—early diagnosis and treatment are critical